Systems, devices, and methods are described in which Intrinsic Frequency calculation (direct and/or by approximation) of a pulse pressure waveform is used make a determination of metabolic syndrome and/or insulin resistance or sensitivity. The pulse pressure waveform may be obtained non-invasively using a smartphone platform or be otherwise obtained.